But in addition to the recurrent structural deficit and the bad economy, New Jersey faces several worrisome prospects this year.
In addition to the recurrent gains and losses that are concordant with those by the experimental CGH, vCGH also identified a few recurrent abnormalities not shown by CGH, such as gains of 6q and losses of 1q and 8q on DLBCL, and those regions are significantly correlated with the patients' outcomes.
In addition to the common recurrent gains and losses between vCGH and CGH, vCGH also predicted some recurrent gains or losses that were not observed in CGH, such as gains of 1p (in 33 out of 190 samples), 2q (39/190) and 6q (37/190) and losses of 1q (25/190), 6p (44/190) and 8q (19/190) on the DLBCL dataset.
In addition to the 22q11.2 region, recurrent deletions and duplications at 7q11.3, 15q11 q13, 16p11.2, and 17p11.2 have autism as a frequent phenotypic presentation [ Cook and Scherer 2008; Stankiewicz and Lupski, 2010).
In addition to the function in the recurrent reward circuit, MBON-α1 mediates retrieval of the LTM trace in the MB.
The few samples that had slightly higher HES5 expression also had low HES6 expression (Fig. 3f), which although not compelling alone is consistent with our other data supporting an inverse relationship between HES5 and HES6 in addition to highlighting the recurrent silencing of HES5 in tumourigenesis.
In addition to these recurrent CNVs, two genes, NRXN1 and VIPR2, have also been associated with schizophrenia when disrupted by non-recurrent CNVs with different breakpoints (8– 10).
In a phenotype-driven screen, the Myshkin (Myk) dominant mutant was selected due to its small size in addition to the presence of spontaneous, recurrent convulsive seizures and was originally presented as a model of epilepsy (85).
The Hamming distance values, in addition to the high frequency of recurrent mutations, support the idea of a form of mutational robustness [ 34- 36] evolving in the system through a quasispecies behavior in ligase populations evolved in vitro, although a formal test of this will require a comparison of fitness values.
IVIG treatment represents an important component of the combination therapy of CAPS and they could be useful, in addition to the standard therapy, to prevent recurrent thrombosis in APS patients refractory to conventional anticoagulant treatment.
In addition to the high risk of developing recurrent cancer, treated patients have a 1 4% risk per year for developing a second primary bronchogenic carcinoma [ 18].
